Erythropoietin Receptor Signaling Mitigates Renal Dysfunction-Associated Heart Failure by Mechanisms Unrelated to Relief of Anemia
- 1 November 2010
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 56 (23), 1949-1958
- https://doi.org/10.1016/j.jacc.2010.04.068
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 36 references indexed in Scilit:
- Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failureCardiovascular Research, 2010
- Partial nephrectomy as a model for uremic cardiomyopathy in the mouseAmerican Journal of Physiology-Renal Physiology, 2008
- Correction of Anemia with Erythropoietin in Chronic Kidney Disease (stage 3 or 4): Effects on Cardiac PerformanceCardiovascular Drugs and Therapy, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Erythropoietin, Modified to Not Stimulate Red Blood Cell Production, Retains Its Cardioprotective PropertiesJournal of Pharmacology and Experimental Therapeutics, 2005
- Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia‐reperfusion injuryThe FASEB Journal, 2004
- Erythropoietin‐induced excessive erythrocytosis activates the tissue endothelin system in miceThe FASEB Journal, 2002
- Progression of heart failure: A role for interstitial fibrosisMolecular and Cellular Biochemistry, 1995
- Direct vasopressor effect of recombinant human erythropoietin on renal resistance vesselsKidney International, 1991
- Impact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney International, 1989